Behavioral Medicine Division, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
J Relig Health. 2021 Aug;60(4):2646-2661. doi: 10.1007/s10943-021-01185-x. Epub 2021 Feb 11.
Individuals with cystic fibrosis (CF) face a challenging disease, and depression is a significant concern. Many patients draw on religious/spiritual resources to assist them in managing the demands of chronic illness; however, these coping efforts rarely have been evaluated among adults with CF. This longitudinal study examined relationships between distinct types of positive and negative religious/spiritual coping at baseline (assessed with the RCOPE) and depression screening outcomes 12 month later (assessed with the Hospital Anxiety and Depression Scale). In logistic regression analyses controlling for disease severity (FEV% predicted), lower likelihood of depression caseness at 12 months was predicted by higher general religiousness at baseline, greater use of benevolent religious reappraisal coping, greater use of spiritual connection coping, and lower spiritual discontent. Results suggest that distinct aspects religious/spiritual coping have differential associations with subsequent depression outcomes. Findings extend prior research to an important, understudied medical population, and address a clinically meaningful outcome.
个体患有囊性纤维化（CF），面临着严峻的疾病挑战，而抑郁是一个重大问题。许多患者利用宗教/精神资源来帮助他们应对慢性疾病的需求；然而，这些应对努力在 CF 成年患者中很少得到评估。这项纵向研究考察了基线时不同类型的积极和消极宗教/精神应对方式（使用 RCOPE 评估）与 12 个月后抑郁筛查结果（使用医院焦虑和抑郁量表评估）之间的关系。在控制疾病严重程度（FEV%预测值）的逻辑回归分析中，基线时一般宗教性越高、更多地使用仁慈的宗教再评价应对、更多地使用精神联系应对以及较低的精神不满，与 12 个月时较低的抑郁发病可能性相关。结果表明，宗教/精神应对的不同方面与随后的抑郁结果存在不同的关联。研究结果扩展到一个重要的、研究不足的医学人群，并且解决了一个具有临床意义的结果。
